9 METERS BIOPHARMA, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
9 Meters Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2015 to Q1 2023.
  • 9 Meters Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$13.9M, a 22.2% decline year-over-year.
  • 9 Meters Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$46.3M, a 8.39% decline year-over-year.
  • 9 Meters Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$43.8M, a 19% decline from 2021.
  • 9 Meters Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$36.8M, a 40.2% increase from 2020.
  • 9 Meters Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$61.5M, a 127% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$46.3M -$13.9M -$2.52M -22.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$43.8M -$11.9M -$2.37M -24.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$41.4M -$9.35M +$4.19M +30.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$45.6M -$11.1M -$2.88M -34.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-08
Q1 2022 -$42.7M -$11.4M -$5.92M -109% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$36.8M -$9.55M -$4.59M -92.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$32.2M -$13.5M -$5.21M -62.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$27M -$8.25M +$36.3M +81.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$63.3M -$5.43M -$1.83M -50.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$61.5M -$4.96M +$3.94M +44.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$65.4M -$8.33M +$888K +9.63% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$66.3M -$44.6M -$40.1M -894% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$26.2M -$3.6M +$832K +18.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$27M -$8.9M -$4.69M -111% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$22.4M -$9.22M -$8.45M -1088% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$13.9M -$4.49M -$273K -6.47% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$13.6M -$4.43M +$10.5M +70.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$24.2M -$4.21M -$1.83M -77.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$22.3M -$776K +$1.68M +68.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$24M -$4.22M -$1.43M -51.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$22.6M -$15M -$11M -275% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$11.6M -$2.38M -$1.12M -88.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$10.5M -$2.45M -$617K -33.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$9.87M -$2.79M -$1.55M -125% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$8.32M -$3.99M -$2.11M -112% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$6.21M -$1.26M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$1.83M -$366K -24.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$1.24M -$84K -7.27% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$1.88M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-19
Q3 2015 -$1.47M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-16
Q2 2015 -$1.16M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.